ZYBT (Jilin Zhengye Biotechnology) Company Total Assets

Zhengye Biotechnology leverages the expertise of Chinese biochemists and veterinarians to develop vaccines that ensure food security. Management maintains a conservative approach, navigating the specifics of the local jurisdiction with moderate operational transparency. The company aims for leadership in the agricultural sector by launching new products and upgrading its capacities. This chart of total assets, with a value of 65.02, is presented below.

The expansion of veterinary production at Zhengye Biotechnology (ZYBT) is directly reflected in the fluctuations of assets and resources. This indicator combines equity and liabilities, demonstrating the total value of all resources controlled by the company. The value is calculated inversely via the daily ROA metric, which allows for the tracking of capital management efficiency. A stable trend confirms business resilience in the absence of aggressive mergers and impairment risks.